arrow
P

Per Eriksson

karolinska institutet
H指数:97
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multi-omics approach uncovers causality of IL6R on endotypes of subclinical carotid atherosclerosis and the possible role of the IL6R/OSMR pathway

多组学方法揭示了IL6R对亚临床颈动脉粥样硬化表型的因果性以及IL6R/OSMR通路可能的作用

2025-10-010
PRE
In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

抗中性粒细胞胞浆抗体相关血管炎疾病表现的深入分析识别出独特的临床表型

2025-03-030
OAAI
Enhancing Cardiovascular Risk Prediction with a Simplified Carotid IMT Protocol: Evidence from the IMPROVE Study
2025-02-260
OAAI
A functional genomic framework to elucidate novel causal metabolic dysfunction-associated fatty liver disease genes
2024-08-270
OAAI
Determinants of Carotid Wall Echolucency in a Cohort of European High Cardiovascular Risk Subjects: A Cross-Sectional Analysis of IMPROVE Baseline Data
2024-03-262
OAAI
Novel Association of the NOTCH Pathway Regulator MIB1 Gene With the Development of Bicuspid Aortic Valve
2023-08-0115
OA
Causal analysis of plasma IL-8 on carotid intima media thickness, a measure of subclinical atherosclerosis
2023-01-015
OAAI
Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells (vol 13, 4287, 2022)

全基因组关联研究确定Sjogren的风险位点与免疫和腺细胞的功能意义 (卷13,4287,2022)

2022-10-314
OAAI
Plaque Evaluation by Ultrasound and Transcriptomics Reveals BCLAF1 as a Regulator of Smooth Muscle Cell Lipid Transdifferentiation in Atherosclerosis

通过超声和转录组学评估斑块显示BCLAF1是动脉粥样硬化中平滑肌细胞脂质转分化的调节剂

2022-05-0117
OA